Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cipla
Colorcon
Express Scripts
Daiichi Sankyo
Teva
US Army
Citi
McKinsey

Generated: April 23, 2018

DrugPatentWatch Database Preview

OXTRIPHYLLINE Drug Profile

« Back to Dashboard

When do Oxtriphylline patents expire, and when can generic versions of Oxtriphylline launch?

Oxtriphylline is a drug marketed by Morton Grove and Watson Labs and is included in four NDAs.

The generic ingredient in OXTRIPHYLLINE is oxtriphylline. There are three drug master file entries for this compound. Additional details are available on the oxtriphylline profile page.
Drug patent expirations by year for OXTRIPHYLLINE
Synonyms for OXTRIPHYLLINE
1,3-dimethyl-2-oxopurin-6-olate; 2-hydroxyethyl(trimethyl)azanium
1,3-dimethyl-2,6-dioxo-7H-purin-7-ide; choline
13930-27-3
146-71-4
3K045XR58X
4499-40-5
56553-57-2
AC1LCVCP
AKOS025392171
API0015829
CCG-213695
CHEMBL1200434
Choline theophyllinate
Choline theophyllinate (INN)
Choline theophyllinate [INN]
Choline theophylline
Choline theophylline (JAN)
CHOLINETHIEOPHYLLINATE
cholintheophyllinat
D02017
DB01303
HMS2094A07
KS-1426
MolPort-035-783-495
NSC-760431
NSC760431
Oxtriphylline (USP)
Oxtriphylline [USP]
Oxytrimethylline
Pharmakon1600-01505759
SCHEMBL152854
SCHEMBL4629
Theocolin
Theocolin (TN)
Theophyline - choline mixt
UNII-3K045XR58X

US Patents and Regulatory Information for OXTRIPHYLLINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Morton Grove OXTRIPHYLLINE oxtriphylline SOLUTION;ORAL 088243-001 Dec 5, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Morton Grove OXTRIPHYLLINE PEDIATRIC oxtriphylline SYRUP;ORAL 088242-001 Dec 5, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs OXTRIPHYLLINE oxtriphylline TABLET, DELAYED RELEASE;ORAL 087866-001 Aug 25, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs OXTRIPHYLLINE oxtriphylline TABLET, DELAYED RELEASE;ORAL 087835-001 Aug 25, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Colorcon
Daiichi Sankyo
Accenture
Medtronic
Farmers Insurance
Merck
Fish and Richardson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.